109 related articles for article (PubMed ID: 21226986)
1. Dynamics in children and adolescents who experience varicella zoster virus infections after haematopoietic stem cell transplantation: a case-control study.
Aytaç S; Yalçin SS; Küçükbayrak O; Çetın M; Uçkan D
Epidemiol Infect; 2011 Nov; 139(11):1701-9. PubMed ID: 21226986
[TBL] [Abstract][Full Text] [Related]
2. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
[TBL] [Abstract][Full Text] [Related]
3. Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings.
Viner K; Perella D; Lopez A; Bialek S; Newbern C; Pierre R; Spells N; Watson B
J Infect Dis; 2012 May; 205(9):1336-41. PubMed ID: 22454467
[TBL] [Abstract][Full Text] [Related]
4. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience.
Berman JN; Wang M; Berry W; Neuberg DS; Guinan EC
Bone Marrow Transplant; 2006 Jan; 37(1):73-80. PubMed ID: 16247423
[TBL] [Abstract][Full Text] [Related]
5. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
[TBL] [Abstract][Full Text] [Related]
6. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
7. Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.
Vermont CL; Jol-van der Zijde EC; Hissink Muller P; Ball LM; Bredius RG; Vossen AC; Lankester AC
Transpl Infect Dis; 2014 Apr; 16(2):188-94. PubMed ID: 24438482
[TBL] [Abstract][Full Text] [Related]
8. A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation.
Offidani M; Corvatta L; Olivieri A; Mele A; Brunori M; Montanari M; Rupoli S; Scalari P; Leoni P
Clin Infect Dis; 2001 May; 32(10):1414-22. PubMed ID: 11317241
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
[TBL] [Abstract][Full Text] [Related]
10. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
Han CS; Miller W; Haake R; Weisdorf D
Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
[TBL] [Abstract][Full Text] [Related]
11. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
Goldman GS
Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
[TBL] [Abstract][Full Text] [Related]
12. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
[TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus.
Leibovitz E; Cooper D; Giurgiutiu D; Coman G; Straus I; Orlow SJ; Lawrence R
Pediatrics; 1993 Dec; 92(6):838-42. PubMed ID: 7901834
[TBL] [Abstract][Full Text] [Related]
15. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.
Weinberg A; Wiznia AA; LaFleur BJ; Shah S; Levin MJ
J Infect Dis; 2004 Jul; 190(2):267-70. PubMed ID: 15216460
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant.
Mao J; McPheeters JT; Zhang D; Acosta CJ; Finelli L
Curr Med Res Opin; 2018 Apr; 34(4):741-749. PubMed ID: 28945107
[TBL] [Abstract][Full Text] [Related]
17. One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group.
Oshima K; Takahashi T; Mori T; Matsuyama T; Usuki K; Asano-Mori Y; Nakahara F; Okamoto S; Kurokawa M; Kanda Y
Transpl Infect Dis; 2010 Oct; 12(5):421-7. PubMed ID: 20626711
[TBL] [Abstract][Full Text] [Related]
18. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002.
Jumaan AO; Yu O; Jackson LA; Bohlke K; Galil K; Seward JF
J Infect Dis; 2005 Jun; 191(12):2002-7. PubMed ID: 15897984
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
[TBL] [Abstract][Full Text] [Related]
20. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
Hata A; Asanuma H; Rinki M; Sharp M; Wong RM; Blume K; Arvin AM
N Engl J Med; 2002 Jul; 347(1):26-34. PubMed ID: 12097537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]